• Title/Summary/Keyword: viral RNA

Search Result 478, Processing Time 0.029 seconds

New Concepts on Vaccine Development for the Poultry Diseases

  • Han, M.G.
    • Korean Journal of Poultry Science
    • /
    • v.28 no.2
    • /
    • pp.165-172
    • /
    • 2001
  • Vaccination is one of the most important and cost-effective methods of preventing infectious diseases. Over the past decade, scientific in molecular biology and immunology have improved understanding of many diseases and led to the development of novel strategies for vaccination. An ideal vaccine would induce effective immunity specific for the type of infection, have long duration, require minimal or no boosters, have safety, would not induce adverse reaction, and be easy to administer. The desire to meet these criteria has resulted in the development of vaccines that do not depend on the use of the viable disease agent. It is not the intent of this review to give an extensive review of the field of vaccinology, but rather to address characteristics of conventional and genetically engineered vaccines.

  • PDF

Evaluation of Inhibitory Effects of Thiobarbituric Acid Derivatives Targeting HCV NS5B Polymerase

  • Lee, Jong-Ho;Lee, Sang-Yoon;Park, Mi-Young;Ha, Hyun-Joon;Myung, Hee-Joon
    • Journal of Microbiology and Biotechnology
    • /
    • v.20 no.3
    • /
    • pp.510-512
    • /
    • 2010
  • A series of thiobarbituric acid derivatives were constructed and evaluated for inhibitory activity on hepatitis C virus NS5B polymerase. In biochemical assays using purified viral polymerase and RNA template, the $IC_{50}$ value was improved to 0.41 ${\mu}M$ from the original compound's 1.7 ${\mu}M$ value. In HCV sub genomic replicon assay, the $EC_{50}$ value was improved to 3.7 ${\mu}M$ from the original compound's 12.3 ${\mu}M$ value. $CC_{50}$ was higher than 77 ${\mu}M$ for all compounds tested, suggesting that they are useful candidates for anti-HCV therapy.

Cloning and Sequence Analysis of Hog Cholera Virus(HCV) E2 Gene (돼지 콜레라 바이러스 E2 유전자의 클로닝 및 염기서열분석)

  • 이영기;강신웅;김선원;박성원;이종철;이청호
    • Journal of the Korean Society of Tobacco Science
    • /
    • v.23 no.2
    • /
    • pp.103-108
    • /
    • 2001
  • Hog cholera virus(HCV) was purified from virus infected Bovine kidney cells. From this virus, total protein was analyzed by SDS-PAGE gel electrophoresis and about 55 kDa band of E2 envelope protein was detected. The viral RNA was purified and E2 cDNA was amplified by RT-PCR. E2 cDNA fragment was cloned to PCRII-TOPO cloning vector and named pE2. The analysis of nucleotide sequence showed that this E2 cDNA fragment inserted into pE2 was 1191 nucleotides long and coded 397 amino acids.

  • PDF

Studies on Properties of Avian Reovirus Isolated in Korea (국내에서 분리한 닭 레오바이러스의 성상에 관한 연구)

  • 김성식;박병옥;김순재
    • Korean Journal of Veterinary Service
    • /
    • v.15 no.1
    • /
    • pp.67-80
    • /
    • 1992
  • Avian reoviruses have been implicated in respiratory disease enteric conditions including Cloacal pasting in young thicks, pericarditis, hydropericardium, anaemia with swollen spleen and liver and petechiation of skeletal muscle and viral arthritis. This study was conducted to examine properties of reovirus field 3 strains isolated from affected broiler from several farms. An infectious agent was isolated from leg tendons and intestine of broiler with clinical tenosynovitis. The agent grew well on the chicken embryo kideny cells(CEK). One of them produced cytopathic effects(CPE) of round type and formed intranuclear inclusions, and the other was characterized by CPE of syncytical type and cytoplasmic inclusion. The properties and serological classification of field strains were examined by hemagglutin test, virus neutralization test, agar gel precipitin, electropherotype. They showed no hemagglutination reactions and not well neutralization and to possess common antigens detectable by AGP test. RNA electropherotype presented 10 segment band as the previous report. These data suggest that the field strains and standard strains (1133, 1733) may be the same group.

  • PDF

Evolution of avian infectious bronchitis virus: Genetic drift and recombination

  • Lee, Chang-Won
    • Korean Journal of Veterinary Service
    • /
    • v.25 no.1
    • /
    • pp.97-103
    • /
    • 2002
  • Infectious bronchitis(IB) is a viral disease in which continued evolution of the virus is of paramount importance for annual endemics and epidemics in chickens. Since the isolation of IB viruses(IBVs) in the 1930s, over 50 serotypes or variants have been reported worldwide. Continuing evolution is most prominent in the suface glycoproteins of IBV but also occurs in other parts of the genome. This genetic variability results from accumulation of molecular changes that can occur by a number of different mechanisms including genetic drift (point mutations) and genetic shift(RNA recombination). GA98 is a new serotype of IBV identified recently in the United States. In this paper, the evolutionary trend of IBV will be discussed using GA98 serotype as a model.

Differential Expression of HCV Core Protein from Two Different Quasispecies

  • Yu, Kyung-Lee;You, Ji-Chang
    • Biomolecules & Therapeutics
    • /
    • v.17 no.2
    • /
    • pp.151-155
    • /
    • 2009
  • Hepatitis C virus (HCV) has genetic diversity like most of RNA viruses. HCV major genotypes are classified into several subtypes which are further divided into quasispecies having, genetically different but closely related variants. The HCV core that is a nucleocapsid protein located at the amino terminus of the viral polyprotein is relatively a conserved protein among the HCV isolates and thus it has been one of plausible targets for anti-HCV drug development. However, different quasispecies of HCV core gene have also been found. In this study, we compared the expression level of core protein between two different quasispecies of HCV genotype 1b. Our data demonstrate that a little differences of amino acid sequence lead to substantial difference of expression level. It might be another important reason of different pathogenesis among HCV infected patients.

Updates on the coronavirus disease 2019 vaccine and consideration in children

  • Kang, Hyun Mi;Choi, Eun Hwa;Kim, Yae-Jean
    • Clinical and Experimental Pediatrics
    • /
    • v.64 no.7
    • /
    • pp.328-338
    • /
    • 2021
  • Humanity has been suffering from the global severe acute respiratory syndrome coronavirus 2 pandemic that began late in 2019. In 2020, for the first time in history, new vaccine platforms-including mRNA vaccines and viral vector-based DNA vaccines-have been given emergency use authorization, leading to mass vaccinations. The purpose of this article is to review the currently most widely used coronavirus disease 2019 vaccines, investigate their immunogenicity and efficacy data, and analyze the vaccine safety profiles that have been published, to date.

Identification of Chinese Yam Necrotic Mosaic Virus(ChYNMV) infecting Chinese yam(Dioscorea opposita Thunb. cv. Jang-Ma) in Korea.

  • D. K. Kang;H. Y. Shin;J. H. Sung;Park, J. H.;M. U. Chang
    • Proceedings of the Korean Society of Plant Pathology Conference
    • /
    • 2003.10a
    • /
    • pp.151.1-151
    • /
    • 2003
  • Chinese yam(D. opposita Thunb. cv. Jang-Ma) plants showing necrotic mosaic symptom were collected from their growing fields in Andong, Korea. Electron microscoptic examination of negatively stained preparations showed filamentous particles of 660nm in length. The virues purified partially were used to isolate Viral RNA as template for RT-PCR to amplify the CP gene with ChYNMV specific and oligo dT primers. Amino acids sequeces revealed that the viruses shared 99.3% similarity with ChYNMV(AB044386) which was known as the member of macluravirus. So the viruses from Chinese yam(D. opposita Thunb. cv. Jang-Ma) plants were identified as ChYNMV. Comparing the amino aced sequences of ChYNMV strains with other macluraviruses such as CdMV, NLV and MacMV revealed that N-terminal was the most variable region and conserved regions were present within the genus Macluravirus.

  • PDF

The complex role of extracellular vesicles in HIV infection

  • Jung-Hyun Lee
    • BMB Reports
    • /
    • v.56 no.6
    • /
    • pp.335-340
    • /
    • 2023
  • During normal physiological and abnormal pathophysiological conditions, all cells release membrane vesicles, termed extracellular vesicles (EVs). Growing evidence has revealed that EVs act as important messengers in intercellular communication. EVs play emerging roles in cellular responses and the modulation of immune responses during virus infection. EVs contribute to triggering antiviral responses to restrict virus infection and replication. Conversely, the role of EVs in the facilitation of virus spread and pathogenesis has been widely documented. Depending on the cell of origin, EVs carry effector functions from one cell to the other by horizontal transfer of their bioactive cargoes, including DNA, RNA, proteins, lipids, and metabolites. The diverse constituents of EVs can reflect the altered states of cells or tissues during virus infection, thereby offering a diagnostic readout. The exchanges of cellular and/or viral components by EVs can inform the therapeutic potential of EVs for infectious diseases. This review discusses recent advances of EVs to explore the complex roles of EVs during virus infection and their therapeutic potential, focusing on HIV-1.

Occurrence of erythema multiforme following COVID-19 vaccination: a review

  • Marzieh Yousefian;Alireza Khadivi
    • Clinical and Experimental Vaccine Research
    • /
    • v.12 no.2
    • /
    • pp.87-96
    • /
    • 2023
  • The fast development of vaccines against the novel coronavirus disease is among the most critical steps taken to control this potentially fatal viral disease. Like other vaccines, the coronavirus disease 2019 (COVID-19) vaccines can also cause unwanted reactions. Erythema multiforme (EM) is among the oral mucocutaneous side effects of COVID-19 vaccines. This study aimed to comprehensively review the reported cases of EM since the global onset of COVID-19 vaccination. Data from 31 relevant studies regarding the type and dose of COVID-19 vaccines administered, time of initiation of symptoms, age, and gender of patients, site of involvement, patients' medical history, and treatment options were extracted. In total, 90 patients were identified with EM as a side effect of COVID-19 vaccination across studies. EM had the highest frequency after receiving the first dose of mRNA vaccines in older individuals. The first symptoms of EM appeared in less than 3 days in 45% and after 3 days in 55% of patients. EM is not a common side effect of COVID-19 vaccination, and fear of its occurrence should not impede vaccination.